Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity

Obesity is a complex medical condition that affects multiple organs in the body. However, the underlying mechanisms of obesity, as well as its treatment, are largely unexplored. The focus of this research was to use bioinformatics to discover possible treatment targets for obesity. To begin, the GSE...

Full description

Bibliographic Details
Main Authors: Yun Yu, Yu-Han Zhang, Liang Liu, Ling-Ling Yu, Jun-Pei Li, Jing-an Rao, Feng Hu, Ling-Juan Zhu, Hui-Hui Bao, Xiao-Shu Cheng
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Adipocyte
Subjects:
Online Access:http://dx.doi.org/10.1080/21623945.2021.2013406
_version_ 1798034132871151616
author Yun Yu
Yu-Han Zhang
Liang Liu
Ling-Ling Yu
Jun-Pei Li
Jing-an Rao
Feng Hu
Ling-Juan Zhu
Hui-Hui Bao
Xiao-Shu Cheng
author_facet Yun Yu
Yu-Han Zhang
Liang Liu
Ling-Ling Yu
Jun-Pei Li
Jing-an Rao
Feng Hu
Ling-Juan Zhu
Hui-Hui Bao
Xiao-Shu Cheng
author_sort Yun Yu
collection DOAJ
description Obesity is a complex medical condition that affects multiple organs in the body. However, the underlying mechanisms of obesity, as well as its treatment, are largely unexplored. The focus of this research was to use bioinformatics to discover possible treatment targets for obesity. To begin, the GSE133099 database was used to identify 364 differentially expressed genes (DEGs). Then, DEGs were subjected to tissue-specific analyses and enrichment analyses, followed by the creation of a protein-protein interaction (PPI) network and generation of a drug-gene interaction database to screen key genes and potential future drugs targeting obesity. Findings have illustrated that the tissue-specific expression of neurologic markers varied significantly (34.7%, 52/150). Among these genes, Lep, ApoE, Fyn, and FN1 were the key genes observed in the adipocyte samples from obese patients relative to the controls. Furthermore, nine potential therapeutic drugs (dasatinib, ocriplasmin, risperidone, gemfibrozil, ritonavir, fluvastatin, pravastatin, warfarin, atorvastatin) that target the key genes were also screened and selected. To conclude the key genes discovered (Lep, ApoE, Fyn, and FN1), as well as 9 candidate drugs, could be used as therapeutic targets in treating obesity.
first_indexed 2024-04-11T20:40:00Z
format Article
id doaj.art-9afa2b3f454d4341ae1eb90485775062
institution Directory Open Access Journal
issn 2162-3945
2162-397X
language English
last_indexed 2024-04-11T20:40:00Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Adipocyte
spelling doaj.art-9afa2b3f454d4341ae1eb904857750622022-12-22T04:04:15ZengTaylor & Francis GroupAdipocyte2162-39452162-397X2022-12-0111111010.1080/21623945.2021.20134062013406Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesityYun Yu0Yu-Han Zhang1Liang Liu2Ling-Ling Yu3Jun-Pei Li4Jing-an Rao5Feng Hu6Ling-Juan Zhu7Hui-Hui Bao8Xiao-Shu Cheng9Second Affiliated Hospital of Nanchang UniversityMaternal and Child Health Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversitySecond Affiliated Hospital of Nanchang UniversityObesity is a complex medical condition that affects multiple organs in the body. However, the underlying mechanisms of obesity, as well as its treatment, are largely unexplored. The focus of this research was to use bioinformatics to discover possible treatment targets for obesity. To begin, the GSE133099 database was used to identify 364 differentially expressed genes (DEGs). Then, DEGs were subjected to tissue-specific analyses and enrichment analyses, followed by the creation of a protein-protein interaction (PPI) network and generation of a drug-gene interaction database to screen key genes and potential future drugs targeting obesity. Findings have illustrated that the tissue-specific expression of neurologic markers varied significantly (34.7%, 52/150). Among these genes, Lep, ApoE, Fyn, and FN1 were the key genes observed in the adipocyte samples from obese patients relative to the controls. Furthermore, nine potential therapeutic drugs (dasatinib, ocriplasmin, risperidone, gemfibrozil, ritonavir, fluvastatin, pravastatin, warfarin, atorvastatin) that target the key genes were also screened and selected. To conclude the key genes discovered (Lep, ApoE, Fyn, and FN1), as well as 9 candidate drugs, could be used as therapeutic targets in treating obesity.http://dx.doi.org/10.1080/21623945.2021.2013406obesityadipocytetissue-specific gene expressiondrug-gene interactionbioinformaticsbiomarkers
spellingShingle Yun Yu
Yu-Han Zhang
Liang Liu
Ling-Ling Yu
Jun-Pei Li
Jing-an Rao
Feng Hu
Ling-Juan Zhu
Hui-Hui Bao
Xiao-Shu Cheng
Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
Adipocyte
obesity
adipocyte
tissue-specific gene expression
drug-gene interaction
bioinformatics
biomarkers
title Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
title_full Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
title_fullStr Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
title_full_unstemmed Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
title_short Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
title_sort bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
topic obesity
adipocyte
tissue-specific gene expression
drug-gene interaction
bioinformatics
biomarkers
url http://dx.doi.org/10.1080/21623945.2021.2013406
work_keys_str_mv AT yunyu bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT yuhanzhang bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT liangliu bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT linglingyu bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT junpeili bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT jinganrao bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT fenghu bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT lingjuanzhu bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT huihuibao bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity
AT xiaoshucheng bioinformaticsanalysisofcandidategenesandpotentialtherapeuticdrugstargetingadiposetissueinobesity